These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34503139)

  • 1. The Landscape of Pediatric Precision Oncology: Program Design, Actionable Alterations, and Clinical Trial Development.
    Langenberg KPS; Looze EJ; Molenaar JJ
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors.
    Lee JW; Kim NKD; Lee SH; Cho HW; Ma Y; Ju HY; Yoo KH; Sung KW; Koo HH; Park WY
    PLoS One; 2019; 14(11):e0224227. PubMed ID: 31747416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable Alterations.
    Pastorino F; Capasso M; Brignole C; Giglio S; Bensa V; Cantalupo S; Lasorsa VA; Tondo A; Mura R; Sementa AR; Garaventa A; Ponzoni M; Amoroso L
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision Medicine in Relapsed and Refractory Childhood Cancers: Single-center Experience, Literature Review, and Meta-analysis.
    Mordechai O; Weyl-Ben-Arush M
    Rambam Maimonides Med J; 2018 Jul; 9(3):. PubMed ID: 30089094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study.
    Harris MH; DuBois SG; Glade Bender JL; Kim A; Crompton BD; Parker E; Dumont IP; Hong AL; Guo D; Church A; Stegmaier K; Roberts CWM; Shusterman S; London WB; MacConaill LE; Lindeman NI; Diller L; Rodriguez-Galindo C; Janeway KA
    JAMA Oncol; 2016 May; 2(5):608-615. PubMed ID: 26822149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS.
    Chaix J; Schleiermacher G; Corradini N; André N; Thebaud E; Gambart M; Defachelles AS; Entz-Werle N; Chastagner P; De Carli É; Ducassou S; Landman-Parker J; Adam-de-Beaumais T; Larive A; Michiels S; Vassal G; Valteau-Couanet D; Geoerger B; Berlanga P
    Eur J Cancer; 2024 Apr; 201():113923. PubMed ID: 38377775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing data on targeted therapy from the INFORM registry platform for children with relapsed cancer in Sweden.
    Wallin S; Øra I; Prochazka G; Sandgren J; Björklund C; Ljungman G; Vogt H; Ek T; van Tilburg CM; Nilsson A
    Front Oncol; 2024; 14():1340099. PubMed ID: 38357207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.
    Mody RJ; Wu YM; Lonigro RJ; Cao X; Roychowdhury S; Vats P; Frank KM; Prensner JR; Asangani I; Palanisamy N; Dillman JR; Rabah RM; Kunju LP; Everett J; Raymond VM; Ning Y; Su F; Wang R; Stoffel EM; Innis JW; Roberts JS; Robertson PL; Yanik G; Chamdin A; Connelly JA; Choi S; Harris AC; Kitko C; Rao RJ; Levine JE; Castle VP; Hutchinson RJ; Talpaz M; Robinson DR; Chinnaiyan AM
    JAMA; 2015 Sep; 314(9):913-25. PubMed ID: 26325560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative.
    Pishvaian MJ; Bender RJ; Halverson D; Rahib L; Hendifar AE; Mikhail S; Chung V; Picozzi VJ; Sohal D; Blais EM; Mason K; Lyons EE; Matrisian LM; Brody JR; Madhavan S; Petricoin EF
    Clin Cancer Res; 2018 Oct; 24(20):5018-5027. PubMed ID: 29954777
    [No Abstract]   [Full Text] [Related]  

  • 12. INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies.
    van Tilburg CM; Witt R; Heiss M; Pajtler KW; Plass C; Poschke I; Platten M; Harting I; Sedlaczek O; Freitag A; Meyrath D; Taylor L; Balasubramanian GP; Jäger N; Pfaff E; Jones BC; Milde T; Pfister SM; Jones DTW; Kopp-Schneider A; Witt O
    BMC Cancer; 2020 Jun; 20(1):523. PubMed ID: 32503469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection.
    Cani AK; Dolce EM; Darga EP; Hu K; Liu CJ; Pierce J; Bradbury K; Kilgour E; Aung K; Schiavon G; Carroll D; Carr TH; Klinowska T; Lindemann J; Marshall G; Rowlands V; Harrington EA; Barrett JC; Sathiyayogan N; Morrow C; Sero V; Armstrong AC; Baird R; Hamilton E; Im SA; Jhaveri K; Patel MR; Dive C; Tomlins SA; Udager AM; Hayes DF; Paoletti C
    Mol Oncol; 2022 May; 16(10):1969-1985. PubMed ID: 34866317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'.
    Langenberg KPS; Meister MT; Bakhuizen JJ; Boer JM; van Eijkelenburg NKA; Hulleman E; Ilan U; Looze EJ; Dierselhuis MP; van der Lugt J; Breunis W; Schild LG; Ober K; van Hooff SR; Scheijde-Vermeulen MA; Hiemcke-Jiwa LS; Flucke UE; Kranendonk MEG; Wesseling P; Sonneveld E; Punt S; Boltjes A; van Dijk F; Verwiel ETP; Volckmann R; Hehir-Kwa JY; Kester LA; Koudijs MMJ; Waanders E; Holstege FCP; Vormoor HJ; Hoving EW; van Noesel MM; Pieters R; Kool M; Stumpf M; Blattner-Johnson M; Balasubramanian GP; Van Tilburg CM; Jones BC; Jones DTW; Witt O; Pfister SM; Jongmans MCJ; Kuiper RP; de Krijger RR; Wijnen MHW; den Boer ML; Zwaan CM; Kemmeren P; Koster J; Tops BBJ; Goemans BF; Molenaar JJ
    Eur J Cancer; 2022 Nov; 175():311-325. PubMed ID: 36182817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.
    Worst BC; van Tilburg CM; Balasubramanian GP; Fiesel P; Witt R; Freitag A; Boudalil M; Previti C; Wolf S; Schmidt S; Chotewutmontri S; Bewerunge-Hudler M; Schick M; Schlesner M; Hutter B; Taylor L; Borst T; Sutter C; Bartram CR; Milde T; Pfaff E; Kulozik AE; von Stackelberg A; Meisel R; Borkhardt A; Reinhardt D; Klusmann JH; Fleischhack G; Tippelt S; Dirksen U; Jürgens H; Kramm CM; von Bueren AO; Westermann F; Fischer M; Burkhardt B; Wößmann W; Nathrath M; Bielack SS; Frühwald MC; Fulda S; Klingebiel T; Koscielniak E; Schwab M; Tremmel R; Driever PH; Schulte JH; Brors B; von Deimling A; Lichter P; Eggert A; Capper D; Pfister SM; Jones DT; Witt O
    Eur J Cancer; 2016 Sep; 65():91-101. PubMed ID: 27479119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM.
    Heipertz AE; Pajtler KW; Pfaff E; Schramm K; Blattner-Johnson M; Milde T; Jones BC; Zuliani C; Hutter C; Lohi O; Kattamis A; Dachowska-Kalwak I; Nilsson A; Gerber NU; Langenberg KPS; Goemans B; Zwaan CM; Molenaar JJ; Jäger N; Dirksen U; Witt R; Pfister SM; Jones DTW; Kopp-Schneider A; Witt O; van Tilburg CM
    JCO Precis Oncol; 2023 Jun; 7():e2300015. PubMed ID: 37364231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice.
    Martens UM; Schröder J; Bengsch F; Sellmann L; Busies S; Frank-Gleich S; Zaiss M; Decker T; Schneeweiss A; Schuler M; Grebhardt S; Zacharias S; Marschner N; Kasenda B; Potthoff K; Vannier C
    BMC Cancer; 2023 Jun; 23(1):543. PubMed ID: 37312086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers.
    Khater F; Vairy S; Langlois S; Dumoucel S; Sontag T; St-Onge P; Bittencourt H; Dal Soglio D; Champagne J; Duval M; Leclerc JM; Laverdiere C; Tran TH; Patey N; Ellezam B; Perreault S; Piché N; Samson Y; Teira P; Jabado N; Michon B; Brossard J; Marzouki M; Cellot S; Sinnett D
    JAMA Netw Open; 2019 Apr; 2(4):e192906. PubMed ID: 31026031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.
    Oberg JA; Glade Bender JL; Sulis ML; Pendrick D; Sireci AN; Hsiao SJ; Turk AT; Dela Cruz FS; Hibshoosh H; Remotti H; Zylber RJ; Pang J; Diolaiti D; Koval C; Andrews SJ; Garvin JH; Yamashiro DJ; Chung WK; Emerson SG; Nagy PL; Mansukhani MM; Kung AL
    Genome Med; 2016 Dec; 8(1):133. PubMed ID: 28007021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Top advances of the year: Precision oncology.
    Desai A; Reddy NK; Subbiah V
    Cancer; 2023 Jun; 129(11):1634-1642. PubMed ID: 36946766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.